Semaglutide vs. Tirzepatide: Peptide Mechanisms and Approved Uses
Semaglutide targets the GLP-1 receptor, while tirzepatide targets both GIP and GLP-1 receptors. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.